{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:42:43Z","timestamp":1789180963167,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10067-026-07937-y","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T01:57:40Z","timestamp":1768787860000},"page":"921-933","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Unraveling the connection and pathogenesis of systemic lupus erythematosus and thyroid cancer: integrative meta-analysis, Mendelian randomization, and transcriptomic insights"],"prefix":"10.1007","volume":"45","author":[{"given":"Qi","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4649-4400","authenticated-orcid":false,"given":"Shu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"issue":"9","key":"7937_CR1","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1056\/NEJMra071297","volume":"358","author":"A Rahman","year":"2008","unstructured":"Rahman A, Isenberg DA (2008) Systemic lupus erythematosus. N Engl J Med 358(9):929\u2013939","journal-title":"N Engl J Med"},{"issue":"3","key":"7937_CR2","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1136\/ard-2022-223035","volume":"82","author":"J Tian","year":"2023","unstructured":"Tian J, Zhang D, Yao X, Huang Y, Lu Q (2023) Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study. Ann Rheum Dis 82(3):351\u2013356","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"7937_CR3","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.amjmed.2010.08.006","volume":"123","author":"YJ Chen","year":"2010","unstructured":"Chen YJ, Chang YT, Wang CB, Wu CY (2010) Malignancy in systemic lupus erythematosus: a nationwide cohort study in Taiwan. Am J Med 123(12):1150\u20131151","journal-title":"Am J Med"},{"key":"7937_CR4","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jaut.2012.12.009","volume":"42","author":"S Bernatsky","year":"2013","unstructured":"Bernatsky S, Ramsey-Goldman R, Labrecque J et al (2013) Cancer risk in systemic lupus: an updated international multi-centre cohort study. J Autoimmun 42:130\u2013135","journal-title":"J Autoimmun"},{"issue":"10061","key":"7937_CR5","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1016\/S0140-6736(16)30172-6","volume":"388","author":"ME Cabanillas","year":"2016","unstructured":"Cabanillas ME, McFadden DG, Durante C (2016) Thyroid cancer. Lancet 388(10061):2783\u20132795","journal-title":"Lancet"},{"key":"7937_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23094631","author":"D Grimm","year":"2022","unstructured":"Grimm D (2022) Recent advances in thyroid cancer research. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23094631","journal-title":"Int J Mol Sci"},{"issue":"10387","key":"7937_CR7","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(23)00020-X","volume":"401","author":"DW Chen","year":"2023","unstructured":"Chen DW, Lang B, McLeod D, Newbold K, Haymart MR (2023) Thyroid cancer. Lancet 401(10387):1531\u20131544","journal-title":"Lancet"},{"issue":"3","key":"7937_CR8","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1089\/thy.2021.0361","volume":"32","author":"L Shobab","year":"2022","unstructured":"Shobab L, Burman KD, Wartofsky L (2022) Sex differences in differentiated thyroid cancer. Thyroid 32(3):224\u2013235","journal-title":"Thyroid"},{"issue":"13","key":"7937_CR9","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1001\/jama.2017.2719","volume":"317","author":"H Lim","year":"2017","unstructured":"Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM (2017) Trends in thyroid cancer incidence and mortality in the United States, 1974-2013. JAMA 317(13):1338\u20131348","journal-title":"JAMA"},{"issue":"12","key":"7937_CR10","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.eprac.2021.09.006","volume":"27","author":"MR Haymart","year":"2021","unstructured":"Haymart MR (2021) Progress and challenges in thyroid cancer management. Endocr Pract 27(12):1260\u20131263","journal-title":"Endocr Pract"},{"key":"7937_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00082","volume":"11","author":"D Laha","year":"2020","unstructured":"Laha D, Nilubol N, Boufraqech M (2020) New therapies for advanced thyroid cancer. Front Endocrinol (Lausanne) 11:82","journal-title":"Front Endocrinol (Lausanne)"},{"key":"7937_CR12","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqad118","author":"LJ Leandro-Garcia","year":"2023","unstructured":"Leandro-Garcia LJ, Landa I (2023) Mechanistic insights of thyroid cancer progression. Endocrinology. https:\/\/doi.org\/10.1210\/endocr\/bqad118","journal-title":"Endocrinology"},{"issue":"2","key":"7937_CR13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/acr2.11105","volume":"2","author":"Y Klionsky","year":"2020","unstructured":"Klionsky Y, Antonelli M (2020) Thyroid disease in lupus: an updated review. ACR Open Rheumatol 2(2):74\u201378","journal-title":"ACR Open Rheumatol"},{"issue":"3","key":"7937_CR14","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.kint.2020.04.044","volume":"98","author":"Z Yu","year":"2020","unstructured":"Yu Z, Coresh J, Qi G et al (2020) A bidirectional Mendelian randomization study supports causal effects of kidney function on blood pressure. Kidney Int 98(3):708\u2013716","journal-title":"Kidney Int"},{"key":"7937_CR15","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jad.2023.08.086","volume":"341","author":"H Qi","year":"2023","unstructured":"Qi H, Wen FY, Xie YY et al (2023) Associations between depressive, anxiety, stress symptoms and elevated blood pressure: findings from the CHCN-BTH cohort study and a two-sample Mendelian randomization analysis. J Affect Disord 341:176\u2013184","journal-title":"J Affect Disord"},{"key":"7937_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535","journal-title":"BMJ"},{"issue":"16","key":"7937_CR17","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","volume":"326","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW, Richmond RC, Woolf B et al (2021) Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement. JAMA 326(16):1614\u20131621","journal-title":"JAMA"},{"issue":"12","key":"7937_CR18","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/ng.3434","volume":"47","author":"J Bentham","year":"2015","unstructured":"Bentham J, Morris DL, Graham D et al (2015) Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat Genet 47(12):1457\u20131464","journal-title":"Nat Genet"},{"issue":"1","key":"7937_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21049-y","volume":"12","author":"YF Wang","year":"2021","unstructured":"Wang YF, Zhang Y, Lin Z et al (2021) Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity between ancestral groups. Nat Commun 12(1):772","journal-title":"Nat Commun"},{"issue":"10","key":"7937_CR20","doi-asserted-by":"publisher","first-page":"E1674","DOI":"10.1210\/jc.2013-1941","volume":"98","author":"A Kohler","year":"2013","unstructured":"Kohler A, Chen B, Gemignani F et al (2013) Genome-wide association study on differentiated thyroid cancer. J Clin Endocrinol Metab 98(10):E1674\u2013E1681","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"7937_CR21","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","volume":"53","author":"S Sakaue","year":"2021","unstructured":"Sakaue S, Kanai M, Tanigawa Y et al (2021) A cross-population atlas of genetic associations for 220 human phenotypes. Nat Genet 53(10):1415\u20131424","journal-title":"Nat Genet"},{"issue":"3","key":"7937_CR22","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/EDE.0000000000000081","volume":"25","author":"TJ VanderWeele","year":"2014","unstructured":"VanderWeele TJ, Tchetgen TE, Cornelis M, Kraft P (2014) Methodological challenges in mendelian randomization. Epidemiology 25(3):427\u2013435","journal-title":"Epidemiology"},{"issue":"3","key":"7937_CR23","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ije\/dyr036","volume":"40","author":"S Burgess","year":"2011","unstructured":"Burgess S, Thompson SG (2011) Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol 40(3):755\u2013764","journal-title":"Int J Epidemiol"},{"issue":"3","key":"7937_CR24","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/ije\/dyy195","volume":"48","author":"W Spiller","year":"2019","unstructured":"Spiller W, Slichter D, Bowden J, Davey SG (2019) Detecting and correcting for bias in Mendelian randomization analyses using gene-by-environment interactions. Int J Epidemiol 48(3):702\u2013712","journal-title":"Int J Epidemiol"},{"issue":"21","key":"7937_CR25","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1002\/sim.6522","volume":"34","author":"MF Greco","year":"2015","unstructured":"Greco MF, Minelli C, Sheehan NA, Thompson JR (2015) Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome. Stat Med 34(21):2926\u20132940","journal-title":"Stat Med"},{"key":"7937_CR26","doi-asserted-by":"publisher","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.1","volume":"4","author":"S Burgess","year":"2019","unstructured":"Burgess S, Davey SG, Davies NM et al (2019) Guidelines for performing Mendelian randomization investigations: update for summer 2023. Wellcome Open Res 4:186","journal-title":"Wellcome Open Res"},{"issue":"3","key":"7937_CR27","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.berh.2017.09.013","volume":"31","author":"MY Choi","year":"2017","unstructured":"Choi MY, Flood K, Bernatsky S, Ramsey-Goldman R, Clarke AE (2017) A review on SLE and malignancy. Best Pract Res Clin Rheumatol 31(3):373\u2013396","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"7937_CR28","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1210\/jc.2009-0677","volume":"95","author":"A Antonelli","year":"2010","unstructured":"Antonelli A, Mosca M, Fallahi P et al (2010) Thyroid cancer in systemic lupus erythematosus: a case-control study. J Clin Endocrinol Metab 95(1):314\u2013318","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"7937_CR29","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s40618-017-0757-0","volume":"41","author":"F Boi","year":"2018","unstructured":"Boi F, Pani F, Calo PG, Lai ML, Mariotti S (2018) High prevalence of papillary thyroid carcinoma in nodular Hashimoto\u2019s thyroiditis at the first diagnosis and during the follow-up. J Endocrinol Invest 41(4):395\u2013402","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"7937_CR30","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s12016-018-8709-9","volume":"56","author":"JM Anaya","year":"2019","unstructured":"Anaya JM, Restrepo-Jimenez P, Rodriguez Y et al (2019) Sjogren\u2019s syndrome and autoimmune thyroid disease: two sides of the same coin. Clin Rev Allergy Immunol 56(3):362\u2013374","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"7937_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-021-00984-1","volume":"23","author":"A Weinstein","year":"2021","unstructured":"Weinstein A, Alexander RV, Zack DJ (2021) A review of complement activation in SLE. Curr Rheumatol Rep 23(3):16","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"7937_CR32","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.cyto.2014.12.027","volume":"72","author":"RM Talaat","year":"2015","unstructured":"Talaat RM, Mohamed SF, Bassyouni IH, Raouf AA (2015) Th1\/Th2\/Th17\/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: correlation with disease activity. Cytokine 72(2):146\u2013153","journal-title":"Cytokine"},{"issue":"1","key":"7937_CR33","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12967-023-03943-9","volume":"21","author":"Y Sui","year":"2023","unstructured":"Sui Y, Li S, Fu XQ, Zhao ZJ, Xing S (2023) Bioinformatics analyses of combined databases identify shared differentially expressed genes in cancer and autoimmune disease. J Transl Med 21(1):109","journal-title":"J Transl Med"},{"issue":"5","key":"7937_CR34","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1158\/1078-0432.CCR-05-2378","volume":"12","author":"G Salvatore","year":"2006","unstructured":"Salvatore G, De Falco V, Salerno P et al (2006) BRAF is a therapeutic target in aggressive thyroid carcinoma. Clin Cancer Res 12(5):1623\u20131629","journal-title":"Clin Cancer Res"},{"issue":"2","key":"7937_CR35","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41574-023-00920-6","volume":"20","author":"I Landa","year":"2024","unstructured":"Landa I, Cabanillas ME (2024) Genomic alterations in thyroid cancer: biological and clinical insights. Nat Rev Endocrinol 20(2):93\u2013110","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"7937_CR36","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1158\/1078-0432.CCR-06-1753","volume":"13","author":"D Liu","year":"2007","unstructured":"Liu D, Hu S, Hou P, Jiang D, Condouris S, Xing M (2007) Suppression of BRAF\/MEK\/MAP kinase pathway restores expression of iodide-metabolizing genes in thyroid cells expressing the V600E BRAF mutant. Clin Cancer Res 13(4):1341\u20131349","journal-title":"Clin Cancer Res"},{"issue":"Pt B","key":"7937_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110968","volume":"124","author":"S Song","year":"2023","unstructured":"Song S, Zhang JY, Liu FY, Zhang HY, Li XF, Zhang SX (2023) B cell subsets-related biomarkers and molecular pathways for systemic lupus erythematosus by transcriptomics analyses. Int Immunopharmacol 124(Pt B):110968","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"7937_CR38","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40364-016-0064-5","volume":"4","author":"D Borg","year":"2016","unstructured":"Borg D, Hedner C, Gaber A et al (2016) Expression of IFITM1 as a prognostic biomarker in resected gastric and esophageal adenocarcinoma. Biomark Res 4:10https:\/\/doi.org\/10.1186\/s40364-016-0064-5","journal-title":"Biomark Res"},{"issue":"4","key":"7937_CR39","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s40291-020-00469-4","volume":"24","author":"R Liang","year":"2020","unstructured":"Liang R, Li X, Zhu X (2020) Deciphering the roles of IFITM1 in tumors. Mol Diagn Ther 24(4):433\u2013441","journal-title":"Mol Diagn Ther"},{"key":"7937_CR40","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.canlet.2021.05.006","volume":"514","author":"OK Provance","year":"2021","unstructured":"Provance OK, Geanes ES, Lui AJ et al (2021) Disrupting interferon-alpha and NF-kappaB crosstalk suppresses IFITM1 expression attenuating triple-negative breast cancer progression. Cancer Lett 514:12\u201329","journal-title":"Cancer Lett"},{"key":"7937_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21144934","author":"S Sakamoto","year":"2020","unstructured":"Sakamoto S, Inoue H, Kohda Y, Ohba SI, Mizutani T, Kawada M (2020) Interferon-induced transmembrane protein 1 (IFITM1) promotes distant metastasis of small cell lung cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21144934","journal-title":"Int J Mol Sci"},{"issue":"7","key":"7937_CR42","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2022111112","volume":"42","author":"X She","year":"2023","unstructured":"She X, Shen S, Chen G et al (2023) Immune surveillance of brain metastatic cancer cells is mediated by IFITM1. EMBO J 42(7):e111112","journal-title":"EMBO J"},{"issue":"1","key":"7937_CR43","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s13046-023-02872-1","volume":"42","author":"R Xu","year":"2023","unstructured":"Xu R, Lee YJ, Kim CH et al (2023) Invasive FoxM1 phosphorylated by PLK1 induces the polarization of tumor-associated macrophages to promote immune escape and metastasis, amplified by IFITM1. J Exp Clin Cancer Res 42(1):302","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"7937_CR44","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/cac2.12149","volume":"41","author":"H Li","year":"2021","unstructured":"Li H, Liang J, Wang J et al (2021) Mex3a promotes oncogenesis through the RAP1\/MAPK signaling pathway in colorectal cancer and is inhibited by hsa-miR-6887-3p. Cancer Commun 41(6):472\u2013491","journal-title":"Cancer Commun"},{"key":"7937_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8090334","author":"CK Looi","year":"2020","unstructured":"Looi CK, Hii LW, Ngai SC, Leong CO, Mai CW (2020) The role of Ras-associated protein 1 (Rap1) in cancer: bad actor or good player? Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines8090334","journal-title":"Biomedicines"},{"issue":"3","key":"7937_CR46","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/his.12562","volume":"66","author":"TY Wang","year":"2015","unstructured":"Wang TY, Liu CL, Chen MJ, Lee JJ, Pun PC, Cheng SP (2015) Expression of haem oxygenase-1 correlates with tumour aggressiveness and BRAF V600E expression in thyroid cancer. Histopathology 66(3):447\u2013456","journal-title":"Histopathology"},{"key":"7937_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19092502","author":"PS Yang","year":"2018","unstructured":"Yang PS, Hsu YC, Lee JJ, Chen MJ, Huang SY, Cheng SP (2018) Heme oxygenase-1 inhibitors induce cell cycle arrest and suppress tumor growth in thyroid cancer cells. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms19092502","journal-title":"Int J Mol Sci"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-07937-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-07937-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-07937-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T10:03:51Z","timestamp":1769767431000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-07937-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["7937"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-07937-y","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]},"assertion":[{"value":"23 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research utilized publicly available data. Each participant received ethical approval and informed consent for the respective study, as detailed in the original publication and consortium.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}